Literature DB >> 8396794

IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus.

M M Medveczky1, P Geck, J L Sullivan, D Serbousek, J Y Djeu, P G Medveczky.   

Abstract

Herpesvirus saimiri is a primate tumor virus and induces acute T cell lymphomas and leukemias in New World monkeys and rabbits. We show in this report that infection of human peripheral white blood cells with a group C strain 484-77 results in selective expansion of CD8 lymphocytes with strong cytotoxic activity and these cells do not require interleukin-2 (IL-2) for growth. Infected cell cultures, termed herpesvirus-activated killer (HAK) cells, have been continuously maintained for several months in tissue culture and these HAK cells contain multiple copies of stable circular viral episomes. The growth and cytotoxicity of HAK cells was found independent of IL-2. Analysis of deletion mutant infected cells suggests that at least two open reading frame sequences of a bicistronic mRNA encoded by the viral genome is involved in controlling IL-2 independence. This model could facilitate studies on growth regulation of human cytotoxic T cells that are important effector cells in immune responses against infectious diseases and cancer and should help us to elucidate the mechanism of transformation by H. saimiri oncogenes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396794     DOI: 10.1006/viro.1993.1495

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Functional characterization and conformational analysis of the Herpesvirus saimiri Tip-C484 protein.

Authors:  Jennifer L Mitchell; Ronald P Trible; Lori A Emert-Sedlak; David D Weis; Edwina C Lerner; Jeremy J Applen; Bartholomew M Sefton; Thomas E Smithgall; John R Engen
Journal:  J Mol Biol       Date:  2006-12-16       Impact factor: 5.469

4.  Functional phenotype of transformed human alphabeta and gammadelta T cells determined by different subgroup C strains of herpesvirus Saimiri.

Authors:  H Fickenscher; C Bökel; A Knappe; B Biesinger; E Meinl; B Fleischer; B Fleckenstein; B M Bröker
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Herpesvirus saimiri.

Authors:  H Fickenscher; B Fleckenstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

6.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

Authors:  M E Ballestas; K M Kaye
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Primary structure of the Herpesvirus ateles genome.

Authors:  J C Albrecht
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Herpesvirus ateles Tio can replace herpesvirus saimiri StpC and Tip oncoproteins in growth transformation of monkey and human T cells.

Authors:  Jens-Christian Albrecht; Brigitte Biesinger; Ingrid Müller-Fleckenstein; Doris Lengenfelder; Monika Schmidt; Bernhard Fleckenstein; Armin Ensser
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.

Authors:  H W Virgin; R M Presti; X Y Li; C Liu; S H Speck
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  The Lck binding domain of herpesvirus saimiri tip-484 constitutively activates Lck and STAT3 in T cells.

Authors:  T C Lund; P C Prator; M M Medveczky; P G Medveczky
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.